Martin Mayer

ZETA GmbH
Director Business Line Digital Solutions
Martin Mayer has held a wide variety of senior roles from Strategy and Business Development to Research and Development, to General Management, challenged his skills within more than 15 years of interesting international work.
His strong technical background in combination with strategic and business skills are the base for sustainable solutions for a number of projects in biotech/biopharma industry, in chemical industry, pulp and paper, and in the biotech/biopharma industry mainly in the field of digitization, industrial IoT, machine learning applications, data management, data analytics, and model-based optimization (DoE), both in manufacturing and in laboratory and R&D environment.
At ZETA, Martin is responsible for business development in the field of smart engineering services and digitalisation.
Martin is a member of the ISPE Steering Committee for the Plug & Produce activities within the ISPE Pharma 4.0™ program. He joined ISPE in 2020.

Related Articles

Figure 1: The 4 Ps of the pharmaceutical value chain are interconnected. Each element finds its virtual representation in a digital twin (figure © Zeta).
Features
Driving Biopharma Solutions with Digital Technologies

Developing comprehensive digital solutions is crucial for the entire value creation process for pharmaceuticals. A holistic view of the interrelations of product, production process, and plant is becoming increasingly significant. In this context, the application of model-based technologies provides support in drug development, process scale-up, and manufacturing. Furthermore, it accelerates...